Buserelin

18 interactions 3 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Lenvatinib Histrelin Implant Hydroxychloroquine Inotuzumab Ozogamicin Injection Lefamulin Olodaterol Oral Inhalation
18 Major
All (18) Major (18)

Major

Buserelin Sertraline Explained An increased risk of QT interval prolongation Details Buserelin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Buserelin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Buserelin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Buserelin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Buserelin Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Buserelin Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Buserelin Fostemsavir Rukobia Increased risk of torsade de pointes Details Buserelin Glasdegib Daurismo Increased risk of QT interval prolongation Details Buserelin Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Buserelin Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Buserelin Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Buserelin Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Buserelin Lefamulin Xenleta Increased risk of QT interval prolongation Details Buserelin Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Buserelin Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Buserelin Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Buserelin Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.